SAIRA KHADERI

Concepts (153)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
13
2024
938
1.700
Why?
Liver Neoplasms
13
2024
1319
1.520
Why?
Liver Cirrhosis
14
2024
833
1.290
Why?
Early Detection of Cancer
4
2024
356
0.770
Why?
Liver Transplantation
6
2020
1038
0.750
Why?
Alcohol Drinking
2
2024
339
0.710
Why?
Hepatitis C
4
2023
364
0.700
Why?
Alcoholic Beverages
1
2019
18
0.630
Why?
End Stage Liver Disease
3
2018
182
0.630
Why?
Religion
1
2019
46
0.620
Why?
Liver Diseases
2
2018
366
0.560
Why?
Hepacivirus
3
2016
241
0.550
Why?
Alcoholism
1
2019
231
0.530
Why?
Hepatitis B virus
1
2016
136
0.500
Why?
Liver Failure, Acute
1
2016
89
0.490
Why?
Digestive System Neoplasms
1
2015
14
0.490
Why?
Cholangitis, Sclerosing
1
2015
57
0.460
Why?
Hypertension, Portal
1
2014
78
0.430
Why?
Antiviral Agents
2
2016
746
0.410
Why?
Liver Diseases, Alcoholic
2
2023
57
0.400
Why?
Hypertension, Pulmonary
1
2014
433
0.320
Why?
Non-alcoholic Fatty Liver Disease
2
2023
397
0.290
Why?
Esophageal and Gastric Varices
1
2008
64
0.280
Why?
Veterans
1
2018
1751
0.270
Why?
alpha-Fetoproteins
2
2024
132
0.270
Why?
Biomarkers, Tumor
2
2024
1460
0.270
Why?
Gastrointestinal Hemorrhage
1
2008
223
0.250
Why?
Prospective Studies
10
2024
6083
0.250
Why?
Quality Improvement
2
2022
639
0.250
Why?
Risk Factors
11
2024
10137
0.230
Why?
Phospholipases A2, Calcium-Independent
1
2024
13
0.230
Why?
Protein Precursors
1
2024
150
0.220
Why?
Humans
27
2024
124335
0.210
Why?
Bile Acids and Salts
1
2024
244
0.200
Why?
Graft Survival
2
2014
527
0.190
Why?
Middle Aged
14
2024
26443
0.190
Why?
Hepatitis, Viral, Human
1
2020
44
0.170
Why?
Program Development
1
2020
188
0.160
Why?
History, 15th Century
1
2019
14
0.160
Why?
United States
4
2024
10766
0.160
Why?
History, 16th Century
1
2019
27
0.160
Why?
History, Medieval
1
2019
27
0.160
Why?
History, Ancient
1
2019
54
0.160
Why?
Predictive Value of Tests
3
2024
2122
0.160
Why?
Pentanoic Acids
1
2018
3
0.150
Why?
Caspase Inhibitors
1
2018
31
0.150
Why?
Fatty Liver
1
2020
183
0.150
Why?
Transition to Adult Care
1
2020
120
0.150
Why?
Cystatin C
1
2018
51
0.140
Why?
Obesity
3
2024
2250
0.140
Why?
Estrogen Replacement Therapy
1
2017
42
0.140
Why?
Male
16
2024
60990
0.140
Why?
Female
17
2024
66271
0.140
Why?
Aged
10
2024
19461
0.130
Why?
Genome-Wide Association Study
1
2024
1659
0.130
Why?
Risk Assessment
5
2024
3372
0.130
Why?
Genetic Predisposition to Disease
2
2024
3134
0.130
Why?
Sofosbuvir
1
2016
14
0.130
Why?
Patient Care Team
1
2020
546
0.130
Why?
Renal Insufficiency
1
2018
234
0.120
Why?
Gallbladder Neoplasms
1
2015
14
0.120
Why?
Hepatitis B
1
2016
160
0.120
Why?
Endpoint Determination
1
2015
54
0.120
Why?
Glomerular Filtration Rate
1
2018
484
0.120
Why?
Referral and Consultation
1
2018
540
0.120
Why?
United States Department of Veterans Affairs
1
2018
668
0.120
Why?
Bile Ducts, Intrahepatic
1
2015
95
0.120
Why?
Platelet Count
2
2024
136
0.110
Why?
Time Factors
2
2014
6263
0.110
Why?
Treatment Outcome
5
2018
12279
0.110
Why?
Incidence
4
2024
3086
0.110
Why?
Cholangiocarcinoma
1
2015
107
0.110
Why?
Bile Duct Neoplasms
1
2015
110
0.110
Why?
Administration, Intravenous
1
2014
143
0.110
Why?
Administration, Inhalation
1
2014
180
0.110
Why?
Arterial Pressure
1
2014
101
0.110
Why?
Vasodilator Agents
1
2014
200
0.100
Why?
Models, Theoretical
1
2015
358
0.100
Why?
Waiting Lists
1
2014
228
0.100
Why?
Infectious Disease Transmission, Vertical
1
2014
240
0.100
Why?
Administration, Oral
1
2014
677
0.100
Why?
Hepatitis C, Chronic
1
2016
324
0.100
Why?
Drug Therapy, Combination
1
2014
1154
0.090
Why?
Recurrence
1
2014
1425
0.090
Why?
Pulmonary Artery
1
2014
440
0.090
Why?
Retrospective Studies
5
2024
16225
0.080
Why?
Colorectal Neoplasms
1
2015
566
0.080
Why?
Texas
3
2024
3590
0.080
Why?
Genotype
1
2014
2551
0.080
Why?
Portal Pressure
1
2008
5
0.080
Why?
Decision Trees
1
2008
49
0.070
Why?
Hepatic Veins
1
2008
22
0.070
Why?
Sclerotherapy
1
2008
40
0.070
Why?
Ligation
1
2008
135
0.070
Why?
Age Factors
1
2014
2805
0.070
Why?
Decompression, Surgical
1
2008
93
0.070
Why?
Biomarkers
3
2024
2976
0.070
Why?
Esophagoscopy
1
2008
156
0.070
Why?
Angiotensin Receptor Antagonists
1
2008
122
0.070
Why?
Serum Albumin
1
2024
109
0.060
Why?
Prothrombin
1
2024
24
0.060
Why?
Acyltransferases
1
2024
44
0.060
Why?
Bilirubin
1
2024
122
0.060
Why?
Lipase
1
2024
89
0.060
Why?
Alanine Transaminase
1
2024
152
0.060
Why?
Case-Control Studies
2
2024
3267
0.060
Why?
Liver Cirrhosis, Alcoholic
1
2023
36
0.050
Why?
North America
1
2024
240
0.050
Why?
Adolescent
3
2020
19355
0.050
Why?
Genetic Loci
1
2024
333
0.050
Why?
Child, Preschool
2
2015
14075
0.050
Why?
Prognosis
2
2024
4554
0.050
Why?
Proportional Hazards Models
1
2024
1320
0.040
Why?
Adult
3
2018
29376
0.040
Why?
Overweight
1
2023
359
0.040
Why?
Severity of Illness Index
1
2008
2896
0.040
Why?
Patient Care Planning
1
2020
122
0.040
Why?
Sensitivity and Specificity
1
2024
2029
0.040
Why?
Transplant Recipients
1
2020
214
0.040
Why?
Follow-Up Studies
2
2020
5107
0.040
Why?
Keratin-18
1
2018
6
0.040
Why?
Disease Progression
1
2024
2038
0.040
Why?
Quality Indicators, Health Care
1
2020
216
0.040
Why?
Serum
1
2018
47
0.040
Why?
Patient Participation
1
2020
221
0.040
Why?
Placebos
1
2018
241
0.040
Why?
Reproducibility of Results
1
2024
2871
0.040
Why?
Child
2
2015
24516
0.040
Why?
Gastroenterology
1
2020
191
0.030
Why?
Patient Education as Topic
1
2020
443
0.030
Why?
Germ-Line Mutation
1
2019
334
0.030
Why?
Membrane Proteins
1
2024
1530
0.030
Why?
Triglycerides
1
2019
566
0.030
Why?
Sustained Virologic Response
1
2016
41
0.030
Why?
Creatinine
1
2018
382
0.030
Why?
Metabolic Syndrome
1
2019
330
0.030
Why?
Polymorphism, Single Nucleotide
1
2024
2613
0.030
Why?
Double-Blind Method
1
2018
1618
0.030
Why?
Viral Load
1
2016
384
0.030
Why?
Sex Factors
1
2018
1267
0.030
Why?
RNA, Viral
1
2016
539
0.030
Why?
Survival Analysis
1
2017
1482
0.030
Why?
Decision Support Techniques
1
2015
286
0.020
Why?
Inflammation
1
2019
1411
0.020
Why?
Multivariate Analysis
1
2015
1417
0.020
Why?
Surveys and Questionnaires
1
2020
3731
0.020
Why?
Survival Rate
1
2015
2020
0.020
Why?
Cohort Studies
1
2019
4730
0.020
Why?
Aged, 80 and over
1
2018
6467
0.020
Why?
Young Adult
1
2020
8979
0.020
Why?
Postoperative Complications
1
2015
3062
0.010
Why?
Infant, Newborn
1
2015
8183
0.010
Why?
Infant
1
2015
12475
0.010
Why?
KHADERI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (153)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_